Alternatively, despite the lack of evidence of any apparent correlation with cancerous EMT, IQSEC3 was identified as a novel prognostic marker for breast cancer patients [68], and it is known that SCN1A is a possible factor in the development of chemoresistance in esophageal adenocarcinoma [69]. This evidence concerns the gene SCN1A and breast cancer.